To study the role of TGF-β in AML cell survival under conditions mimicking hypoxic BM microenvironment, we investigated the antileukemic effects and molecular mechanisms of action of monoclonal pan–TGF-β-neutralizing antibody, 1D11 [27]. This evidence concerns the gene TGFB1 and acute myeloid leukemia.